Nucleic Acids Research, 1993, Vol. 21, No. 2 215-221
© 1993
MOLECULAR BIOLOGY |
The identification of elements determining the different DNA binding specificities of the MADS box proteins p67SRF and RSRFC4
Max-Planck-lnstitut fur Immunbiologie, Spemann Laboratories Postfach 1169, Stubeweg 51, 7800 Freiburg, Germany
*To whom correspondence should be addressed at Department of Biochemistry and Genetics, The Medical School, The University, Newcastle-upoo-Tyne NE2 4HH, UK
Received October 26, 1992. Revised December 7, 1992. Accepted December 7, 1992.
The human transcription factors p67SRF and RSRFC4 recognise similar but distinct binding sites which are found in the promoters of both muscle-specific and immediate early genes. Both proteins share a common basic DNA-blnding domain, which is defined by the MADS box homology region. The DNA-blnding specificity of a truncated form of p67SRF (coreSRF) can be converted to that of RSRFC4. Removal of residues Immediately N-terminal to the MADS box relaxes the specificity of coreSRF for Its cognate sequence (CC(AT)6GG) as It Improves binding to the RSRFC4 site (CTA(A/T)4TAG). Moreover, the Introduction of a single, additional mutation, K154E, Into the N-terminal truncated derivative completes the change in specificity to the RSRFC4 binding site. It also influences the salt dependence of DNA binding and ternary complex formation with p62TCF. However, residues at this position do not appear to be involved in direct base-pair recognition. These results indicate that although the DNA binding specificity of p67TCF can be converted to that of RSRFC4, the two proteins may bind DNA In different ways. Furthermore, they suggest that binding site specificity can be determined by an Indirect mechanism involving residues which are not directly Involved in base recognition.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. S. Abraham and A. K. Vershon N-Terminal Arm of Mcm1 Is Required for Transcription of a Subset of Genes Involved in Maintenance of the Cell Wall Eukaryot. Cell, November 1, 2005; 4(11): 1808 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Vickers, A. Kasza, I. A. Kurnaz, A. Seifert, L. A. H. Zeef, A. O'Donnell, A. Hayes, and A. D. Sharrocks Ternary Complex Factor-Serum Response Factor Complex-Regulated Gene Activity Is Required for Cellular Proliferation and Inhibition of Apoptotic Cell Death Mol. Cell. Biol., December 1, 2004; 24(23): 10340 - 10351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stinson, T. Inoue, P. Yates, A. Clancy, J. D. Norton, and A. D. Sharrocks Regulation of TCF ETS-domain transcription factors by helix-loop-helix motifs Nucleic Acids Res., August 15, 2003; 31(16): 4717 - 4728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Boros, F.-L. Lim, Z. Darieva, A. Pic-Taylor, R. Harman, B. A. Morgan, and A. D. Sharrocks Molecular determinants of the cell-cycle regulated Mcm1p-Fkh2p transcription factor complex Nucleic Acids Res., May 1, 2003; 31(9): 2279 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-L. Lim, A. Hayes, A. G. West, A. Pic-Taylor, Z. Darieva, B. A. Morgan, S. G. Oliver, and A. D. Sharrocks Mcm1p-Induced DNA Bending Regulates the Formation of Ternary Transcription Factor Complexes Mol. Cell. Biol., January 15, 2003; 23(2): 450 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Roberts, R. W. Deed, T. Inoue, J. D. Norton, and A. D. Sharrocks Id Helix-Loop-Helix Proteins Antagonize Pax Transcription Factor Activity by Inhibiting DNA Binding Mol. Cell. Biol., January 15, 2001; 21(2): 524 - 533. [Abstract] [Full Text] |
||||
![]() |
P. Dalgleish and A. D. Sharrocks The mechanism of complex formation between Fli-1 and SRF transcription factors Nucleic Acids Res., January 15, 2000; 28(2): 560 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ling, A. G. West, E. C. Roberts, J. H. Lakey, and A. D. Sharrocks Interaction of Transcription Factors with Serum Response Factor. IDENTIFICATION OF THE Elk-1 BINDING SURFACE J. Biol. Chem., April 24, 1998; 273(17): 10506 - 10514. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. I. Ornatsky, J. J. Andreucci, and J. C. McDermott A Dominant-Negative Form of Transcription Factor MEF2 Inhibits Myogenesis J. Biol. Chem., December 26, 1997; 272(52): 33271 - 33278. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. I. Ornatsky and J. C. McDermott MEF2 Protein Expression, DNA Binding Specificity and Complex Composition, and Transcriptional Activity in Muscle and Non-muscle Cells J. Biol. Chem., October 4, 1996; 271(40): 24927 - 24933. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shore, L. Bisset, J. Lakey, J. P. Waltho, R. Virden, and A. D. Sharrocks Characterization of the Elk-1 ETS DNA-binding Domain J. Biol. Chem., March 17, 1995; 270(11): 5805 - 5811. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Breitbart, C. Liang, L. Smoot, D. Laheru, V Mahdavi, and B Nadal-Ginard A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage Development, January 8, 1993; 118(4): 1095 - 1106. [Abstract] [PDF] |
||||
![]() |
A. Greenall, N. Willingham, E. Cheung, D. S. Boam, and A. D. Sharrocks DNA Binding by the ETS-domain Transcription Factor PEA3 Is Regulated by Intramolecular and Intermolecular Protein{middle dot}Protein Interactions J. Biol. Chem., May 4, 2001; 276(19): 16207 - 16215. [Abstract] [Full Text] [PDF] |
||||




